

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.74424064 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.74424064 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.72415644 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.25768812 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.20661835 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.14514237 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.59305679 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.34080754 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.28933749 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.28933749 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.28933749 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 5.28933749 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 5.28933749 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.28933749 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.04344455 |
| 16 | detection of other organism (GO:0098543) | 4.99657119 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.98303889 |
| 18 | detection of bacterium (GO:0016045) | 4.95486094 |
| 19 | leukocyte aggregation (GO:0070486) | 4.92218979 |
| 20 | response to interleukin-15 (GO:0070672) | 4.59319784 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.55961752 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.41485815 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.32816053 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.32114569 |
| 25 | response to peptidoglycan (GO:0032494) | 4.23503398 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.21875033 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.21309500 |
| 28 | cellular extravasation (GO:0045123) | 4.08227129 |
| 29 | neutrophil activation (GO:0042119) | 4.08003774 |
| 30 | detection of external biotic stimulus (GO:0098581) | 4.05069024 |
| 31 | respiratory burst (GO:0045730) | 4.03087037 |
| 32 | negative thymic T cell selection (GO:0045060) | 4.02954014 |
| 33 | negative T cell selection (GO:0043383) | 4.01833462 |
| 34 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.96489206 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.91053754 |
| 36 | regulation of B cell differentiation (GO:0045577) | 3.87692984 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.87618826 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.85895895 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.84509167 |
| 40 | response to host immune response (GO:0052572) | 3.78008021 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78008021 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.76809615 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73207068 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72991681 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71596822 |
| 46 | granulocyte activation (GO:0036230) | 3.65115780 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 3.60019289 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.55318956 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.54508049 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.54145550 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.46725760 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.46725760 |
| 53 | response to host (GO:0075136) | 3.46475277 |
| 54 | response to host defenses (GO:0052200) | 3.46475277 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.46475277 |
| 56 | tolerance induction (GO:0002507) | 3.45384297 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44475528 |
| 58 | response to type I interferon (GO:0034340) | 3.44377417 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.43299014 |
| 60 | T cell migration (GO:0072678) | 3.42818009 |
| 61 | B cell mediated immunity (GO:0019724) | 3.42572420 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 3.41838352 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.41702024 |
| 64 | leukocyte degranulation (GO:0043299) | 3.38661559 |
| 65 | positive T cell selection (GO:0043368) | 3.38256537 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.37979032 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.37899294 |
| 68 | microglial cell activation (GO:0001774) | 3.35249935 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.34382082 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34200340 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.33453685 |
| 72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.33453685 |
| 73 | T cell selection (GO:0045058) | 3.29336949 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.28776292 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27636702 |
| 76 | response to muramyl dipeptide (GO:0032495) | 3.26282340 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24745215 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24462630 |
| 79 | thymic T cell selection (GO:0045061) | 3.23971753 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18968958 |
| 81 | defense response to protozoan (GO:0042832) | 3.18402603 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14728962 |
| 83 | negative regulation of innate immune response (GO:0045824) | 3.13862151 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.11965671 |
| 85 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10996108 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 3.10213040 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10203514 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10203514 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 3.09964597 |
| 90 | regulation of mast cell activation (GO:0033003) | 3.08519275 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07215433 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07004496 |
| 93 | macrophage activation (GO:0042116) | 3.06907723 |
| 94 | germinal center formation (GO:0002467) | 3.03469769 |
| 95 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01999469 |
| 96 | activated T cell proliferation (GO:0050798) | 2.97646983 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.96991943 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.94396366 |
| 99 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94305032 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91347825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60757676 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67410698 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01282784 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.75755007 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.67264521 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43183644 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02601991 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.95692755 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91192425 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85367890 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84318852 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83318453 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.78656802 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76386975 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.68800866 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67052804 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.66913185 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.66092004 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.66054240 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.50922499 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45499271 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45266368 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.42072454 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39383376 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36283218 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35210930 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34107641 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.31477976 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.27634915 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21984171 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 2.09295786 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04150952 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03140845 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99221102 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99199323 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99046222 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95267841 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.87993206 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85103585 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83380513 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80282471 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79732780 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74543985 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71691682 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70639413 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68773472 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67243329 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59079906 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48412576 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47589598 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46227255 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45993056 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45746729 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43318983 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43011614 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38697066 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37730103 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37667044 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36288875 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35239120 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33758459 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33661383 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33155797 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31517343 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29449760 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29325318 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27212979 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26159670 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24900977 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24094600 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23409224 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21092693 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20088183 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19259082 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18899688 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17752121 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16858840 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14531352 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14409045 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13191266 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12267539 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12252078 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11741029 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11170882 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09245534 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06748581 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06006387 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05133318 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03988538 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03503768 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00578892 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00566070 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00256898 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97753580 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96893815 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95285826 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93642551 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.91956989 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 0.88451675 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86959691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.62970548 |
| 2 | MP0003436_decreased_susceptibility_to | 4.35239657 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.96785979 |
| 4 | MP0003303_peritoneal_inflammation | 3.41103597 |
| 5 | MP0005671_abnormal_response_to | 3.41101157 |
| 6 | MP0001800_abnormal_humoral_immune | 3.17423612 |
| 7 | MP0002419_abnormal_innate_immunity | 3.09767445 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06061896 |
| 9 | MP0000685_abnormal_immune_system | 3.02138419 |
| 10 | MP0005025_abnormal_response_to | 3.01136786 |
| 11 | MP0001790_abnormal_immune_system | 2.96228262 |
| 12 | MP0005387_immune_system_phenotype | 2.96228262 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.92916519 |
| 14 | MP0009785_altered_susceptibility_to | 2.81730755 |
| 15 | MP0002723_abnormal_immune_serum | 2.79129351 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.78259958 |
| 17 | MP0001819_abnormal_immune_cell | 2.75098309 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.65261529 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.35876557 |
| 20 | MP0006082_CNS_inflammation | 2.35702592 |
| 21 | MP0002398_abnormal_bone_marrow | 2.27175796 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.25327250 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.20143519 |
| 24 | MP0002405_respiratory_system_inflammati | 2.18221284 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.15141145 |
| 26 | MP0000716_abnormal_immune_system | 2.13565792 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.07768371 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.06299719 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.99538871 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.95421387 |
| 31 | MP0002132_abnormal_respiratory_system | 1.92562527 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.88000623 |
| 33 | MP0003866_abnormal_defecation | 1.87647136 |
| 34 | MP0002722_abnormal_immune_system | 1.86625117 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.86290730 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.79627631 |
| 37 | MP0009278_abnormal_bone_marrow | 1.77558015 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.77419412 |
| 39 | MP0002429_abnormal_blood_cell | 1.72462397 |
| 40 | MP0004947_skin_inflammation | 1.68671459 |
| 41 | MP0008260_abnormal_autophagy | 1.67763368 |
| 42 | MP0008469_abnormal_protein_level | 1.48095329 |
| 43 | MP0003828_pulmonary_edema | 1.46332251 |
| 44 | MP0004381_abnormal_hair_follicle | 1.45688034 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.44170432 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.43482981 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.35836749 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.33118718 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.33118718 |
| 50 | MP0009764_decreased_sensitivity_to | 1.32747822 |
| 51 | MP0005310_abnormal_salivary_gland | 1.30948455 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.29986744 |
| 53 | MP0001851_eye_inflammation | 1.28434734 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.26044094 |
| 55 | MP0001873_stomach_inflammation | 1.25502926 |
| 56 | MP0000858_altered_metastatic_potential | 1.22917030 |
| 57 | MP0005451_abnormal_body_composition | 1.12448003 |
| 58 | MP0003075_altered_response_to | 1.07576184 |
| 59 | MP0004883_abnormal_blood_vessel | 1.06175672 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.00411075 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.99973296 |
| 62 | MP0000490_abnormal_crypts_of | 0.97343329 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 0.95337342 |
| 64 | MP0002933_joint_inflammation | 0.92483777 |
| 65 | MP0005166_decreased_susceptibility_to | 0.92004319 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.89261698 |
| 67 | MP0009763_increased_sensitivity_to | 0.88463213 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.87007704 |
| 69 | MP0005390_skeleton_phenotype | 0.85880994 |
| 70 | MP0001663_abnormal_digestive_system | 0.85487437 |
| 71 | MP0004510_myositis | 0.85129058 |
| 72 | MP0002006_tumorigenesis | 0.83690679 |
| 73 | MP0001853_heart_inflammation | 0.82138660 |
| 74 | MP0005164_abnormal_response_to | 0.81055949 |
| 75 | MP0003045_fibrosis | 0.75104678 |
| 76 | MP0003448_altered_tumor_morphology | 0.73932835 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.71471193 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.68842241 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.68541662 |
| 80 | MP0003690_abnormal_glial_cell | 0.67616297 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.63739926 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.63006494 |
| 83 | MP0000343_altered_response_to | 0.62268119 |
| 84 | MP0008004_abnormal_stomach_pH | 0.61650037 |
| 85 | MP0003795_abnormal_bone_structure | 0.61167039 |
| 86 | MP0002009_preneoplasia | 0.60841342 |
| 87 | MP0008874_decreased_physiological_sensi | 0.59102345 |
| 88 | MP0002928_abnormal_bile_duct | 0.56333775 |
| 89 | MP0000249_abnormal_blood_vessel | 0.55669793 |
| 90 | MP0004130_abnormal_muscle_cell | 0.55352340 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.54084477 |
| 92 | MP0000604_amyloidosis | 0.51573680 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.51266103 |
| 94 | MP0003252_abnormal_bile_duct | 0.48009850 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.47489790 |
| 96 | MP0003878_abnormal_ear_physiology | 0.47489790 |
| 97 | MP0000609_abnormal_liver_physiology | 0.44876384 |
| 98 | MP0008873_increased_physiological_sensi | 0.44637720 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.43332715 |
| 100 | MP0005083_abnormal_biliary_tract | 0.43058567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.72645859 |
| 2 | Myositis (HP:0100614) | 5.86471396 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.83980295 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.61253623 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.27707341 |
| 6 | Orchitis (HP:0100796) | 5.23388698 |
| 7 | Stomatitis (HP:0010280) | 5.15596704 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.14263391 |
| 9 | Optic neuritis (HP:0100653) | 4.86957608 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.86957608 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70882072 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.70761738 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.45997494 |
| 14 | Meningitis (HP:0001287) | 4.44406699 |
| 15 | Obstructive lung disease (HP:0006536) | 4.39635620 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.39635620 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.37389399 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 4.15978319 |
| 19 | Encephalitis (HP:0002383) | 3.99417455 |
| 20 | Increased IgE level (HP:0003212) | 3.97257592 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.90217809 |
| 22 | Recurrent skin infections (HP:0001581) | 3.87319408 |
| 23 | Vasculitis (HP:0002633) | 3.77530450 |
| 24 | Urticaria (HP:0001025) | 3.67446241 |
| 25 | Hypochromic anemia (HP:0001931) | 3.67232043 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66982067 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66982067 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.58439658 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.56154568 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.51209316 |
| 31 | Cellulitis (HP:0100658) | 3.50652527 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.47769878 |
| 33 | T lymphocytopenia (HP:0005403) | 3.43319894 |
| 34 | Abnormality of T cell number (HP:0011839) | 3.41449516 |
| 35 | Chest pain (HP:0100749) | 3.38115621 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.35788856 |
| 37 | Abnormality of T cells (HP:0002843) | 3.32899237 |
| 38 | Gingivitis (HP:0000230) | 3.23701300 |
| 39 | Recurrent viral infections (HP:0004429) | 3.15858401 |
| 40 | Increased IgM level (HP:0003496) | 3.15683911 |
| 41 | Granulocytopenia (HP:0001913) | 3.11718446 |
| 42 | Leukocytosis (HP:0001974) | 3.09357677 |
| 43 | Inflammation of the large intestine (HP:0002037) | 3.06073488 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 3.05905958 |
| 45 | Pulmonary infiltrates (HP:0002113) | 3.04742550 |
| 46 | Pustule (HP:0200039) | 3.04452691 |
| 47 | Episodic fever (HP:0001954) | 3.00738353 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 3.00490654 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.97897687 |
| 50 | IgM deficiency (HP:0002850) | 2.90483305 |
| 51 | Lymphopenia (HP:0001888) | 2.88559349 |
| 52 | Hemoptysis (HP:0002105) | 2.88161178 |
| 53 | Epistaxis (HP:0000421) | 2.85215953 |
| 54 | Petechiae (HP:0000967) | 2.81578237 |
| 55 | Gingival bleeding (HP:0000225) | 2.81507062 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74933054 |
| 57 | Arterial thrombosis (HP:0004420) | 2.72919047 |
| 58 | Anorexia (HP:0002039) | 2.69773986 |
| 59 | Pulmonary embolism (HP:0002204) | 2.66200746 |
| 60 | Osteomyelitis (HP:0002754) | 2.61483506 |
| 61 | Microcytic anemia (HP:0001935) | 2.61230869 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.58604775 |
| 63 | Eosinophilia (HP:0001880) | 2.57920131 |
| 64 | Sepsis (HP:0100806) | 2.56222853 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.53708585 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.43827650 |
| 67 | Colitis (HP:0002583) | 2.41770713 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.41015002 |
| 69 | Peritonitis (HP:0002586) | 2.33972192 |
| 70 | Gastrointestinal stroma tumor (HP:0100723) | 2.33632241 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.29456774 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.28864770 |
| 73 | Gangrene (HP:0100758) | 2.25448639 |
| 74 | Recurrent sinusitis (HP:0011108) | 2.24102883 |
| 75 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23743296 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.20433853 |
| 77 | Skin ulcer (HP:0200042) | 2.17190490 |
| 78 | IgG deficiency (HP:0004315) | 2.17102483 |
| 79 | Amyloidosis (HP:0011034) | 2.16764789 |
| 80 | Acute hepatic failure (HP:0006554) | 2.13892734 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.12862787 |
| 82 | Chronic otitis media (HP:0000389) | 2.11663462 |
| 83 | Verrucae (HP:0200043) | 2.11290446 |
| 84 | Papilloma (HP:0012740) | 2.11290446 |
| 85 | Skin rash (HP:0000988) | 2.09788077 |
| 86 | Glomerulopathy (HP:0100820) | 2.09160551 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.08276255 |
| 88 | Purpura (HP:0000979) | 2.07107079 |
| 89 | Abnormality of B cell number (HP:0010975) | 2.04899016 |
| 90 | Recurrent pneumonia (HP:0006532) | 2.03944714 |
| 91 | Increased serum ferritin (HP:0003281) | 2.01879731 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98068809 |
| 93 | Keratitis (HP:0000491) | 1.97764895 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 1.97441252 |
| 95 | Viral hepatitis (HP:0006562) | 1.96996550 |
| 96 | Premature loss of primary teeth (HP:0006323) | 1.96500385 |
| 97 | Abnormality of the pericardium (HP:0001697) | 1.95992429 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94563260 |
| 99 | Joint swelling (HP:0001386) | 1.93361630 |
| 100 | Vertigo (HP:0002321) | 1.92655303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.49391279 |
| 2 | RIPK4 | 4.44954336 |
| 3 | IRAK4 | 3.06973484 |
| 4 | ERN1 | 2.99861734 |
| 5 | FES | 2.89161614 |
| 6 | MAP2K3 | 2.78709787 |
| 7 | BLK | 2.73225048 |
| 8 | GRK6 | 2.71996702 |
| 9 | TNK2 | 2.63867561 |
| 10 | TYK2 | 2.57977855 |
| 11 | CSK | 2.51930938 |
| 12 | TXK | 2.32346264 |
| 13 | PRPF4B | 2.21367422 |
| 14 | ZAP70 | 2.15518586 |
| 15 | BTK | 2.11305560 |
| 16 | SYK | 1.93130429 |
| 17 | JAK3 | 1.91502412 |
| 18 | TAOK3 | 1.84858035 |
| 19 | HCK | 1.83978478 |
| 20 | EPHB1 | 1.78445362 |
| 21 | MAP3K11 | 1.72827511 |
| 22 | IKBKE | 1.68502741 |
| 23 | TAOK1 | 1.58785541 |
| 24 | MAP3K14 | 1.57528503 |
| 25 | KIT | 1.56601543 |
| 26 | MAP3K3 | 1.55765851 |
| 27 | TBK1 | 1.54898746 |
| 28 | TESK2 | 1.50970782 |
| 29 | LYN | 1.47124032 |
| 30 | CSF1R | 1.42277005 |
| 31 | ITK | 1.42048292 |
| 32 | LCK | 1.40731676 |
| 33 | MAP3K13 | 1.39797372 |
| 34 | SIK3 | 1.33198911 |
| 35 | FGR | 1.31166750 |
| 36 | JAK1 | 1.28231673 |
| 37 | JAK2 | 1.28000400 |
| 38 | TEC | 1.16295165 |
| 39 | CDK19 | 1.15948083 |
| 40 | MAP3K1 | 1.15228979 |
| 41 | MARK3 | 1.12681809 |
| 42 | PRKD2 | 1.00871475 |
| 43 | IKBKB | 0.99115486 |
| 44 | KSR2 | 0.94095841 |
| 45 | STK10 | 0.93825426 |
| 46 | SMG1 | 0.93188333 |
| 47 | SIK2 | 0.92031848 |
| 48 | TAOK2 | 0.89703882 |
| 49 | PDK1 | 0.87441342 |
| 50 | TRIB3 | 0.85428531 |
| 51 | MATK | 0.84585629 |
| 52 | MARK2 | 0.83829019 |
| 53 | YES1 | 0.83708033 |
| 54 | PTK6 | 0.82381155 |
| 55 | KDR | 0.77503166 |
| 56 | BMPR2 | 0.77212389 |
| 57 | IRAK1 | 0.73557099 |
| 58 | LRRK2 | 0.72721246 |
| 59 | FYN | 0.70367297 |
| 60 | MAPK12 | 0.69529974 |
| 61 | MAP3K7 | 0.69130787 |
| 62 | PDPK1 | 0.63263322 |
| 63 | PIM1 | 0.61617893 |
| 64 | HIPK2 | 0.57943685 |
| 65 | MAP2K2 | 0.56938358 |
| 66 | IRAK2 | 0.56708787 |
| 67 | * PRKCQ | 0.56475215 |
| 68 | PTK2B | 0.53722081 |
| 69 | MAPK7 | 0.52288768 |
| 70 | DYRK1B | 0.50826779 |
| 71 | PIK3CG | 0.50125614 |
| 72 | STK11 | 0.48694059 |
| 73 | MAP3K6 | 0.47888752 |
| 74 | FGFR4 | 0.47509803 |
| 75 | NLK | 0.45910464 |
| 76 | RPS6KC1 | 0.45551148 |
| 77 | RPS6KL1 | 0.45551148 |
| 78 | CAMKK1 | 0.44208281 |
| 79 | MAP3K5 | 0.43344726 |
| 80 | MAP2K6 | 0.42298398 |
| 81 | PRKCH | 0.40103134 |
| 82 | RPS6KA6 | 0.39897033 |
| 83 | FGFR3 | 0.39811572 |
| 84 | MAPKAPK2 | 0.39155007 |
| 85 | RAF1 | 0.39003662 |
| 86 | CDK4 | 0.38141803 |
| 87 | MAP2K4 | 0.37316075 |
| 88 | SIK1 | 0.36745163 |
| 89 | STK38 | 0.36214392 |
| 90 | MAPK11 | 0.36175704 |
| 91 | RET | 0.35797012 |
| 92 | CDC42BPA | 0.33866571 |
| 93 | PRKG2 | 0.33483749 |
| 94 | EPHA3 | 0.33293964 |
| 95 | TGFBR2 | 0.32744886 |
| 96 | DAPK2 | 0.31692381 |
| 97 | PRKCD | 0.29853750 |
| 98 | BCKDK | 0.28816384 |
| 99 | SGK3 | 0.26039305 |
| 100 | ALK | 0.23602718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.26952309 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.17853882 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.11565607 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05755195 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.95357846 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.81893569 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71134766 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.64489473 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42221835 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.33482744 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17830763 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08365565 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.01683466 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.99585525 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97040876 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.93230419 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92437785 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.92381416 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.90069057 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83135041 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81259931 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.77581183 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.76286420 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75567581 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74145199 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63062406 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60679010 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58771487 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52110384 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50424276 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.48613778 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38208858 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.27313421 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27005009 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19389195 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19050525 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.18725159 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18522488 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17970866 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.16119731 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15613298 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.09882096 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01462781 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.01255244 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00438725 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.96570137 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.93453335 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92687469 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91436583 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88440746 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86187459 |
| 52 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86095308 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85260986 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84652613 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.84247365 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81083578 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.79176807 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75805010 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73427115 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70777790 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.69811186 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67410295 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67049320 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66624989 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62035795 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58458927 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58164409 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57292908 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57152295 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55650083 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52232489 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51417927 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50894517 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50236119 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50213620 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50125493 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50113264 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48779139 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48154007 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48152974 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45690823 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.44764729 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42447905 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40835527 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40124261 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39099108 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38866696 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.37010939 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36446754 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35075935 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34746357 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32588833 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31543455 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.31120775 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28868497 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28097587 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27961029 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27461374 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27244084 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21353358 |

